Trial Profile
A Phase I, Open-label Study to Assess the Pharmacokinetics of Oral Fostamatinib in Healthy Japanese Subjects After Single and Multiple Doses
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Fostamatinib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- 12 Oct 2015 Results published in the European Journal of Clinical Pharmacology
- 21 Aug 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.
- 07 Jun 2012 New trial record